Herpes B virus encephalomyelitis presenting as ophthalmic zoster. A possible latent infection reactivated.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D001037:Aphasia / Q000209:etiology; D001259:Ataxia / Q000209:etiology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D003561:Cytarabine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004679:Encephalomyelitis / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D000882:Haplorhini; D006563:Herpes Zoster Ophthalmicus / Q000175:diagnosis*; D006566:Herpesviridae Infections / Q000188:drug therapy / Q000276:immunology; D006568:Herpesvirus 1, Cercopithecine / Q000302:isolation & purification; D006801:Humans; D007757:Laboratory Infection; D008297:Male; D008875:Middle Aged; D009129:Muscle Tonus; D009882:Ophthalmic Nerve; D010291:Paresis / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D012867:Skin / Q000382:microbiology; D013997:Time Factors; D005719:gamma-Globulins / Q000627:therapeutic use
D000906:Antibodies; D002556:Cerebrospinal Fluid Proteins; D005719:gamma-Globulins; D003561:Cytarabine; D011241:Prednisone